Medical/Pharmaceuticals

SNIPR Biome's data on first clinical drug candidate to prevent infections in hematological cancer patients published in Nature Biotechnology

* SNIPR001 is a novel CRISPR-Cas therapeutic designed to selectively target antibiotic resistantE. coli, which can cause fatal infections in vulnerable hematological cancer patients             * SNIPR001 represents the first CRISPR- therapeutic developed to specifically removeE. coli in the ...

2023-05-05 00:52 3218

National Comprehensive Cancer Network Honors Cancer Leaders who Guide the Future of Care

Theresa J. Franco, Fred & Pamela Buffett Cancer Center; F. Marc Stewart, City of Hope National Medical Center;Douglas E. Wood, UW Medicine Fred Hutchinson Cancer Center; andDonna Powell, NCCN, presented with awards during NCCN 2023 Annual Conference. PLYMOUTH MEETING, Pa., May 4, 2023 /PRNewswir...

2023-05-04 23:00 3102

ANGUS ANNOUNCES CORPORATE REBRANDING, WILL CHANGE NAME TO "ADVANCION"

New name and brand reflect Company's strategic transformation into a leading global producer of specialty ingredients for Life Sciences, Personal Care and other essential markets BUFFALO GROVE, Ill., May 4, 2023 /PRNewswire/ -- ANGUS Chemical Company ("ANGUS" or "Company") today unveiled a new n...

2023-05-04 21:00 5245

Cambridge Infinitus Research Centre Launches World Leading AI-based Technology Platform ERnet for Studies of Cellular Health

GUANGZHOU, China, May 4, 2023 /PRNewswire/ -- The Cambridge Infinitus Research Centre (CIRCE) was officially established in 2015 as Infinitus' first international scientific research collaboration platform outside ofChina. CIRCE recently achieved another scientific and technological breakthrough ...

2023-05-04 16:00 3901

First Subject Enrolled in Boan Biotech's International Multi-Center Phase 3 Clinical Study for Its Denosumab BA6101 & BA1102

YANTAI, China, May 4, 2023 /PRNewswire/ -- Boan Biotech today announced that an international multi-center Phase 3 clinical study for its in-house developed Denosumab Injection (BA6101; BA1102) has been initiated inEurope, the United States, and Japan, and recently the first patient in (FPI) was ...

2023-05-04 14:40 5759

European Wellness Joint Research with Heidelberg University in Journal Publication

HEIDELBERG, Germany, May 4, 2023 /PRNewswire/ -- European Wellness Academy (EWA), a wholly owned subsidiary European Wellness Biomedical Group (EW Group) has entered into a cooperation agreement with Heidelberg University in medical research. The research project, titled "A Tendon Specific Double...

2023-05-04 13:39 3404

George Clinical Applauded by Frost & Sullivan for Its Competitive Differentiation and Leadership in Strategy Execution in the Asia Pacific region

George Clinical cares for its employees, enables business continuity, and builds on its expertise, giving it a competitive industry advantage. SAN ANTONIO, May 4, 2023 /PRNewswire/ -- Frost & Sullivan studied the contract research organization industry and, based on its findings, recognizes Georg...

2023-05-04 11:00 2640

Annalise.ai grows global footprint with expansion into India

Leading global AI radiology company opens new office in Chennai CHENNAI, India, May 4, 2023 /PRNewswire/ -- Annalise.ai, one of the world's largest artificial intelligence (AI) radiology companies, has today announced it is continuing its global expansion with the opening of the Annalise India ...

2023-05-04 10:56 3445

Alma Lasers' Global Expansion and Vision for Holistic Wellness Solutions Unveiled at Fifth 'Alma Academy' in Italy, Attended by Physicians from 46 Countries

CAESAREA, Israel, May 4, 2023 /PRNewswire/ -- Alma Lasers , a Sisram Medical company and a global leader in energy-based medical and aesthetic solutions, is excited to announce the successful opening of the fifth Alma Academy. Nearly 500 physicians from 46 countries ...

2023-05-04 07:22 4335

Formus Labs, Pioneering Developer of AI-Powered 3D Orthopedic Surgery Planning Technology, Receives FDA Clearance

Formus combines AI and biomechanics to empower orthopedic surgeons with fully interactive 3D surgical plans that optimize the preoperative (pre-op) planning process WARSAW, Ind., May 4, 2023 /PRNewswire/ -- Formus Labs today announced it has received 510(k) clearance from the United States Food ...

2023-05-04 06:18 2807

Aktiia's Continual Blood Pressure Solution Shows Comparable Results to ABPM

NEUCHÂTEL, Switzerland, May 4, 2023 /PRNewswire/ -- Aktiia, a health tech startup transforming hypertension care, has announced promising results from a preliminary study comparing their cuff-less and continual blood pressure monitor with traditional ambulatory blood pressure monitors (ABPM). The...

2023-05-04 00:00 3095

SHL Medical and MoonLake Immunotherapeutics collaborate to develop sonelokimab autoinjector

ZUG, Switerland, May 3, 2023 /PRNewswire/ -- SHL Medical, a world-leading provider of advanced drug delivery solutions, announced that it has signed a collaboration agreement with MoonLake Immunotherapeutics, a clinical-stage biotechnology company focused on creating next-level therapies for infl...

2023-05-03 22:43 4382

Lantern Pharma Selects REPROCELL USA to Provide Support for the Phase 2 Harmonic™ Clinical Trial

BELTSVILLE, Md., May 3, 2023 /PRNewswire/ -- Reprocell USA, a CRO, has been awarded a contract to provide support for Lantern Pharma's Phase 2 clinical trial entitled "A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers with Advanced Lung Adenocarcinoma (HARMONIC)". The Harmonic™ s...

2023-05-03 21:00 2720

Healthcare Veteran, Zach Henderson to lead Global Kinetics as CEO

CHARLOTTE, N.C. and MELBOURNE, Australia, May 3, 2023 /PRNewswire/ -- Global Kinetics, the global leader in digital health solutions for neurological conditions, today announced the appointment of Zach Henderson as its new Chief Executive Officer. Zach will also join the Board of Directors.   Za...

2023-05-03 21:00 3939

LenioBio GmbH Announces New CEO

DUSSELDORF, Germany, May 3, 2023 /PRNewswire/ -- LenioBio GmbH, the Düsseldorf-based cell-free protein expression company, has announced that its founder and CEO, Dr.Remberto Martis, will be stepping down as CEO and has proudly named his successor as André Goerke, startingJune 1st, 2023.   Andr...

2023-05-03 20:00 4327

Chula Researchers Develop Rapid MTB Strip Test for Tuberculosis

Lecturers of the Faculty of Allied Health Sciences, Chulalongkorn University have developed the MTB Strip Test Kit for Tuberculosis (TB) diagnosis that's accurate and easy to use, guaranteed by the 2023 Invention Award from the National Research Council of Thailand (NRCT) -- Another hope to reduce...

2023-05-03 11:34 4940

Merck Signs MoU with Ministry of Trade, Industry & Energy and Daejeon City for New Asia Pacific BioProcessing Production Center in South Korea

* MoU with Merck's Life Science business aimed at supporting the region's healthcare ecosystem * Proposed bioprocessing facility to be based in Daejeon City * Further collaboration aims to support emerging biotech companies and academic research DAEJEON CITY, South Korea, May 3, 2023 /PRNe...

2023-05-03 10:00 4430

Sourcing Ideal Medical Device Materials: Experience ICP DAS - BMP medical-grade TPUs at 2023 CMEF Shanghai, China

HSINCHU, May 3, 2023 /PRNewswire/ -- Material "safety" and "quality" are paramount to medical device manufacturers. Therefore, ICP DAS - BMP (Biomedical Polymers), aTaiwan medical-grade TPU (thermoplastic polyurethane) supplier, will partake in CMEF (ICMD) to further make known our highly-stable ...

2023-05-03 09:46 4541

Completion of Enrollment in Cohorts C and G of China Phase II Clinical Study of Osemitamab (TST001) in Combination with CAPOX with or without Nivolumab as First-line Treatment of Gastric/Gastro-esophageal Junction Cancer Patients

SUZHOU, China, May 3, 2023 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics,announces that the enrollment of ...

2023-05-03 08:00 5248

ZEISS Presents New Surgical Workflow Innovations at ASCRS

New products help doctors diagnose and treat patients within the cataract and corneal refractive workflows. JENA, Germany and DUBLIN, Calif., May 3, 2023 /PRNewswire/ -- ZEISS Medical Technology will showcase new surgical workflow innovations at the American Society of Cataract and Refractive Su...

2023-05-03 02:09 3428
1 ... 249250251252253254255 ... 381